Advances in Biotechnological Formulations for Skin Disorders: Delivery Strategies and Biocompatibility
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 547
Special Issue Editors
Interests: nano-based formulations; inflammation; pain management
Interests: drug delivery systems; pharmacokinetics; drug monitoring; health technology assessment; drug safety; natural products
Interests: drug delivery systems; pharmacokinetics; health technology assessment; drug safety; clinical pharmacology; natural products
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Skin disorders represent a significant burden on global healthcare systems, affecting millions of individuals and requiring innovative therapeutic strategies. Advances in biotechnological formulations have paved the way for more effective and targeted treatments for various dermatological conditions. These approaches emphasize biocompatibility, sustained release, and improved skin penetration, ensuring greater efficacy and patient adherence. In particular, the integration of cutting-edge delivery systems, natural ingredients, and biopolymers into these therapies has revolutionized the dermatological landscape, opening up new possibilities in addressing inflammatory, infectious, and chronic skin disorders.
This Special Issue, “Advances in Biotechnological Formulations for Skin Disorders: Delivery Strategies and Biocompatibility,” will provide a platform for disseminating the latest findings in the field of dermatological formulation science. We welcome original research articles and reviews exploring innovative delivery systems and their applications in treating skin disorders, emphasizing formulation and biocompatibility evaluations.
Topics of interest for this Special Issue include, but are not limited to, the following:
- Nanocarriers, such as liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and polymeric nanoparticles, designed to allow enhanced penetration and controlled drug release in skin applications;
- Formulations incorporating probiotics to restore skin microbiome balance and treat conditions such as acne, dermatitis, and psoriasis;
- Biotechnological approaches utilizing natural products, including plant-derived bioactive compounds, essential oils, and extracts with antioxidant, anti-inflammatory, and antimicrobial properties;
- The use of biopolymers, such as polysaccharides and other natural gums, in innovative formulations like hydrogels, films, and emulsions for wound healing and barrier restoration;
- Mechanistic studies on skin absorption, tissue interaction, and the role of formulation excipients in enhancing therapeutic outcomes;
- The evaluation of the safety, efficacy, and stability of novel formulations using in vitro, ex vivo, and in vivo models;
- Applications of advanced formulations in chronic skin conditions, infections, wound management, and cosmetic dermatology
This Special Issue will foster interdisciplinary dialog and share breakthroughs in the development of novel delivery strategies for managing skin disorders. Submissions emphasizing biotechnological innovation, biocompatibility, and translational potential are particularly encouraged.
We look forward to receiving your contributions to this exciting field of research.
Prof. Dr. Marcel Henrique Marcondes Sari
Dr. Raul Edison Luna Lazo
Guest Editors
Dr. Luana Mota Ferreira
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skin disorders
- biotechnological formulations
- nanocarriers
- probiotic-based formulations
- natural products
- polysaccharides
- skin delivery systems
- bioactive compounds
- antioxidant and anti-inflammatory effects
- wound healing
- safety and efficacy in skin therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
